VITAMIN C may prove to be a low-cost option to support people living with diabetes according to a new Deakin Uni study published in the Diabetes, Obesity and Metabolism Journal.
The widely used vitamin was shown, in a randomised cross-over clinical trial, to improve postprandial glycaemic control and blood pressure in individuals with type 2 diabetes.
Authors concluded that ascorbic acid (vit C) could be used as adjunct therapy to improve glycaemic and blood pressure control, especially post-prandially, in these patients.
CLICK HERE to access the research.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Feb 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Feb 19
